CTC Member News

Continuity Control Climbs

January 2012 - In the category of Stage II companies who are growing, Continuity Control has just released some impressive figures that show impressive client acquisition activity in the last quarter of 2011. Continuity added 26 new community financial institution customers in the fourth quarter. The company’s strong regional client base expansion includes Bank of the Sierra and Regents Bank on the West coast, Bank of Southern Connecticut and New Dimensions Federal Credit Union in the Northeast as well as Midwestern clients such as Great Northern Bank and Brainerd Savings and Loan.

 

eSource from Epath
January 2012 - Crowdsourcing, Collaboration cloud computing; the buzz words are all mentioned in ePath Learning, Inc., (a leader in cloud-based learning services), release of eSource, an enterprise social network offering. eSource is a cloud-based service that empowers all employees to contribute, ask questions, share information, connect with colleagues, and search for experts throughout the organization. Employees can collaborate in teams and instantly see what others are working on, share content and post updates. According to ePath, problems are solved organically, and answers to questions are crowd sourced eliminating the silo effect. Go eSource!

Heathcare IT Help from PilotFish Technology
January 2012 - For those of you tracking healthcare technical IT improvements PilotFish Technology announced late last year the early-access release of a first-of-its-kind HL7 Differencing Component. This capability, the latest addition to the XCS eiConsole for Healthcare the HL7 interface engine IDE for configuring interfaces, allows users to rapidly interface systems that use divergent implementations of HL7 messaging protocols. Makes sense to us at CTC.

STR Holdings Names New CEO
December 2011 - New member STR Holdings and 2011 Marcum Tech Top 40 winner, has a new President & CEO. Robert S. Yorgensen has succeeded Dennis L. Jilot as STR’s Chief Executive Officer and President. Yorgensen assumed his new role January 1. Mr. Jilot will continue as Chairman of the Board of Directors. Yorgensen had been President of STR’s solar encapsulant business for the past 14 years, during which time annual revenue grew from $5 million to $259 million.

 

Xerox Acquires LaserNetworks

January 2012 - Xerox, the Norwalk-based developer of office imaging and printing technology, announced the acquisition of Canada's LaserNetworks, a firm that provides print device tracking, centralized service and supply management and document routing. "Our acquisition ... expands our services footprint in Canada, enhancing our capabilities and distancing us from our competitors,” said Mandy Shapansky, president and CEO, Xerox Canada. Terms of the acquisition were not disclosed.

Covidien Agrees to Buy Barrx for $325M

November 2011 - Hartford Business Journal - Drug and medical device maker Covidien PLC,
with a North Haven surgical-tools plant, said
that it will buy privately held Barrx Medical Inc.,
a company that uses radio frequencies to treat
a syndrome often the result of heartburn, that
can lead to esophageal cancer. Covidien expects
to complete the acquisition by Jan 31.

SSM President Nominated for Most Influential People in Sales Lead Management 2011

November 2011 - Farmington - Al Davidson, President of Strategic Sales & Marketing, Inc. (SSM), an industry leader in B2B lead generation, has been nominated for the 50 Most Influential People in Sales Lead Management. Since Al Davidson founded SSM in 1989, the company
has built major account development expertise in business services, high technology, manufacturing and insurance sectors for thousands of companies nationwide.

Boehringer Ingelheim Inks Deal On HIV Treatment

October 2011 - Hartford Business Journal -
Gilead Sciences Inc., with Branford operations,
has obtained global rights to develop and bring
to market an HIV treatment from German pharmaceutical company Boehringer Ingelheim pharmaceuticals whose U.S. headquarters is Ridgefield. Such compounds target the key component of HIV responsible for incorporation
of the viral DNA into the human genome.